Is Liver Transplantation Associated With Decreased Bone Mass In Climacteric Women? [o Transplante Hepático Está Associado A Menor Massa óssea Em Mulheres Climatéricas?]

PURPOSE: To evaluate whether climacteric women undergoing liver transplantation had higher prevalence of decreased bone mass than those without any liver disease. METHODS: A cross-sectional study with 48 women receiving follow-up care at a university hospital in Southeastern Brazil, from February 4th 2009 to January 5th 2011, was conducted. Of these women, 24 were 35 years or older and had undergone liver transplantation at least one year before study entry. The remaining 24 women had no liver disease and their ages and menstrual patterns were similar to those of transplanted patients. Laboratorial tests (follicle-stimulating hormone and estradiol) and bone density measurements of the lumbar spine and femur (equipment Hologic, Discovery WI) were performed. Statistical analysis was carried out by Fisher's exact test, simple Odds Ratio (OR), and multiple logistic regression. RESULTS: Mean age of the women included in the study was 52.8 (±10.7) years-old, 27.1% were premenopausal and 72.9% were peri/postmenopausal. Approximately 14.6% of these women exhibited osteoporosis and 35.4% had low bone mass. The following items were associated with decreased bone mass: being postmenopausal (OR=71.4; 95%CI 3.8-1,339.7; p<0.0001), current age over 49 years-old (OR=11.4; 95%CI 2.9-44.0; p=0.0002), and serum estradiol levels lower than 44.5 pg/mL (OR=18.3; 95%CI 3.4-97.0; p<0.0001). Having a history of liver transplantation was not associated with decreased bone mass (OR=1.4; 95%CI 0.4-4.3; p=0.56). CONCLUSION: Liver transplantation was not associated with decreased bone mass in this group of climacteric women.347335342Baccaro, L.F., Boin, I.F., Pedro, A.O., Costa-Paiva, L., Leal, A.G., Ramos, C.D., Decrease in bone mass in women after liver transplantation: Associated factors (2011) Transplant Proc, 43 (4), pp. 1351-1356Hommann, M., Kammerer, D., Lehmann, G., Kornberg, A., Kupper, B., Daffner, W., Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1 (2007) Transplant Proc, 39 (2), pp. 540-543Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., de Martinez, O.M.J., Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation (1997) Calcif Tissue Int, 60 (2), pp. 148-154Newton, J., Francis, R., Prince, M., James, O., Bassendine, M., Rawlings, D., Osteoporosis in primary biliary cirrhosis revisited (2001) Gut, 49 (2), pp. 282-287Preamor, M.O., Das, T.K., Debiram, I., Parker, R.A., Ninkovic, M., Alexander, G.T., Fracture incidence after liver transplantation: Results of a 10-year audit (2011) QJM, 104 (7), pp. 599-606Jabiry-Zienjewicz, Z., Kaminski, P., Bobrowska, K., Pietrzak, B., Wielgos, M., Zieniewicz, K., Menstrual cycle and sex hormone profile in perimenopausal women after liver transplantation (2006) Transplant Proc, 38 (9), pp. 2909-2912Boin, I.F., Ataide, E.C., Leonardi, M.I., Stucchi, R., Sevá-Pereira, T., Pereira, I.W., Elderly donors for HCV(+) versus non-HCV recipients: Patient survival following liver transplantation (2008) Transplant Proc, 40 (3), pp. 792-796Guañabens, N., Parés, A., Ros, I., Caballeria, L., Pons, F., Vidal, S., Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis (2005) J Hepatol, 42 (4), pp. 573-577Lim, K.B., Schiano, T.D., Long-term outcome after liver transplantation (2012) Mt Sinai J Med, 79 (2), pp. 169-189Compston, J.E., Osteoporosis after liver transplantation (2003) Liver Transpl, 9 (4), pp. 321-330Birkhauser, M.H., Barlow, D.H., Notelovitz, M., Rees, M.C., (2005) Management Handbook: Health Plan For the Adult Woman, , London: Taylor & FrancisBaim, S., Binkley, N., Bilezikian, J.P., Kendler, D.L., Hans, D.B., Lewiecki, E.M., Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference (2008) J Clin Densitom, 11 (1), pp. 75-91Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994) World Health Organ Tech Rep Ser, 843, pp. 1-129. , World Health Organization, Report of a WHO Study GroupSegal, E., Baruch, Y., Kramsky, R., Raz, B., Tamir, A., Ish-Shalom, S., Predominant factors associated with bone loss in liver transplant patients - after prolonged post-transplantation period (2003) Clin Transplant, 17 (1), pp. 13-19Giannini, S., Nobile, M., Dalle, C.L., Ciuffreda, M., Germoni, V., Iemmolo, R.M., Vertebral morphometry by X-ray absorptiometry before and after liver transplant: A crosssectional study (2001) Eur J Gastroenterol Hepatol, 13 (10), pp. 1201-1207Isoniemi, H., Appelberg, J., Nilsson, C.G., Makela, P., Risteli, J., Hockerstedt, K., Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study (2001) J Hepatol, 34 (2), pp. 299-305Sokhi, R.P., Anantharaju, A., Kondaveeti, R., Creech, S.D., Islam, K.K., van Thiel, D.H., Bone mineral density among cirrhotic patients awaiting liver transplantation (2004) Liver Transpl, 10 (5), pp. 648-653Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., de Martinez, O.M.J., Bone disease after liver transplantation: A long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics (2001) Osteoporos Int, 12 (6), pp. 484-492Guichelaar, M.M., Kendall, R., Malinchoc, M., Hay, J.E., Bone mineral densitiy before and after OLT: Long-term follow-up and predictive factors (2006) Liver Transpl, 12 (9), pp. 1390-1402Hay, J.E., Osteoporosis in liver diseases and after liver transplantation (2003) J Hepatol, 38 (6), pp. 856-865Torregrosa, J.V., Campistol, J.M., Montesinos, M., Fenollosa, B., Pons, F., de Martinez, O.M.J., Factors involved in the loss of bone mineral density after renal transplantation (1995) Transplant Proc, 27 (4), pp. 2224-2225Goldstein, M.F., Fallon Jr., J.J., Harning, R., Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease (1999) Chest, 116 (6), pp. 1773-1789Weinstein, R.S., Jilka, R.L., Parfitt, A.M., Manolagas, S.C., Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone (1998) J Clin Invest, 102 (2), pp. 274-282Weinstein, R.S., Chen, J.R., Powers, C.C., Stewart, S.A., Landes, R.D., Bellido, T., Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids (2002) J Clin Invest, 109 (8), pp. 1041-1048Morris, H.A., Need, A.G., O'Loughlin, P.D., Horowitz, M., Bridges, A., Nordin, B.E., Malabsortion of calcium in corticosteroid-induced osteoporosis (1990) Calcif Tissue Int, 46 (5), pp. 305-308Sambrook, P., Birmingham, J., Kempler, S., Kelly, P., Eberl, S., Pocock, N., Corticosteroid effects on proximal femur bone loss (1990) J Bone Miner Res, 5 (12), pp. 1211-1216van Staa, T.P., Leufkens, H.G., Abenhaim, L., Zhang, B., Cooper, C., Use of oral corticosteroids and risk of fractures (2000) J Bone Miner Res, 15 (6), pp. 993-1000Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., de Martínez, O.M.J., Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A (2001) Calcif Tissue Int, 68 (2), pp. 83-86Diaz-Guerra, G.M., Gómez, R., Jódar, E., Loinaz, C., Moreno, E., Hawkins, F., Long-term follow-up of bone mass after orthotopic liver transplantation: Effect of steroid withdrawal from the immunosuppressive regimen (2002) Osteoporos Int, 13 (2), pp. 147-150Stein, E., Ebeling, P., Shane, E., Post-transplantation osteoporosis (2007) Endocrinol Metab Clin North Am, 36 (4), pp. 937-96